| Code | Description | Claims | Beneficiaries | Total Paid |
| 0450 |
Emergency room services |
29,473 |
25,437 |
$2.42M |
| 99199 |
Unlisted special service, procedure or report |
16,724 |
14,255 |
$1.29M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,198 |
2,089 |
$652K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,232 |
4,660 |
$392K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,876 |
1,770 |
$356K |
| 0250 |
|
6,090 |
3,521 |
$343K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,740 |
4,553 |
$333K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,810 |
4,125 |
$280K |
| 80053 |
Comprehensive metabolic panel |
9,609 |
8,557 |
$263K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,195 |
1,171 |
$252K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,727 |
2,477 |
$243K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,182 |
1,153 |
$228K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,668 |
5,184 |
$206K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,467 |
3,104 |
$206K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,106 |
1,798 |
$192K |
| J3490 |
Unclassified drugs |
8,260 |
5,134 |
$187K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,821 |
4,326 |
$179K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,382 |
1,377 |
$165K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,249 |
12,246 |
$156K |
| 82077 |
|
1,018 |
906 |
$148K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,375 |
1,340 |
$133K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
5,640 |
3,114 |
$128K |
| Z7502 |
|
3,083 |
2,961 |
$115K |
| 0270 |
|
2,075 |
1,195 |
$110K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
542 |
522 |
$105K |
| 71046 |
Radiologic examination, chest; 2 views |
3,050 |
2,916 |
$101K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,215 |
1,969 |
$95K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
318 |
305 |
$90K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,706 |
1,681 |
$87K |
| 71045 |
Radiologic examination, chest; single view |
3,964 |
3,605 |
$85K |
| 83880 |
|
2,417 |
2,198 |
$81K |
| 84484 |
|
5,237 |
3,491 |
$70K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,905 |
3,593 |
$70K |
| 96376 |
|
434 |
371 |
$68K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
663 |
651 |
$61K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,044 |
4,293 |
$53K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
297 |
273 |
$44K |
| 80179 |
|
358 |
329 |
$43K |
| 80143 |
|
353 |
326 |
$43K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
263 |
245 |
$42K |
| 73630 |
|
1,046 |
997 |
$42K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
435 |
433 |
$42K |
| 83690 |
|
4,080 |
3,691 |
$42K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,366 |
1,361 |
$41K |
| 73610 |
|
932 |
871 |
$40K |
| 73030 |
|
950 |
907 |
$39K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,116 |
3,813 |
$36K |
| 81001 |
|
5,666 |
5,234 |
$35K |
| 80076 |
|
2,966 |
2,786 |
$34K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,366 |
2,965 |
$32K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,666 |
2,038 |
$31K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
115 |
108 |
$31K |
| 81025 |
|
2,338 |
2,235 |
$30K |
| 73110 |
|
593 |
539 |
$30K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,195 |
1,155 |
$28K |
| 0510 |
|
539 |
245 |
$28K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
93 |
88 |
$28K |
| 87040 |
|
1,317 |
773 |
$24K |
| 73130 |
|
506 |
473 |
$22K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,366 |
2,240 |
$22K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,830 |
1,635 |
$21K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
712 |
617 |
$21K |
| 73564 |
|
465 |
442 |
$20K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
224 |
192 |
$19K |
| 83735 |
|
2,014 |
1,743 |
$19K |
| 76830 |
Ultrasound, transvaginal |
171 |
171 |
$19K |
| 82803 |
|
767 |
650 |
$18K |
| 85379 |
|
1,174 |
1,126 |
$18K |
| 81003 |
|
4,007 |
3,794 |
$18K |
| 83605 |
|
1,055 |
802 |
$15K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,306 |
1,250 |
$13K |
| 0760 |
|
220 |
140 |
$12K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
106 |
106 |
$12K |
| 85610 |
|
2,209 |
1,947 |
$11K |
| 86140 |
|
1,423 |
1,348 |
$10K |
| 87077 |
|
738 |
629 |
$10K |
| 73562 |
|
212 |
200 |
$10K |
| 87186 |
|
923 |
822 |
$10K |
| J2060 |
Injection, lorazepam, 2 mg |
993 |
839 |
$8K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
97 |
91 |
$7K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
927 |
859 |
$7K |
| 87634 |
|
97 |
96 |
$7K |
| 87430 |
|
484 |
469 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
15 |
14 |
$7K |
| 93971 |
|
55 |
53 |
$7K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
14 |
13 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
101 |
99 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
99 |
99 |
$6K |
| 87081 |
|
488 |
473 |
$5K |
| 71250 |
|
29 |
27 |
$5K |
| 73502 |
|
95 |
87 |
$5K |
| 72100 |
|
131 |
123 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
456 |
425 |
$5K |
| 85730 |
|
576 |
546 |
$4K |
| 76641 |
|
54 |
53 |
$4K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
19 |
15 |
$4K |
| 87400 |
|
432 |
410 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
346 |
283 |
$4K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
114 |
67 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
140 |
139 |
$3K |
| 90715 |
|
43 |
43 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
55 |
53 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
153 |
134 |
$2K |
| 84703 |
|
802 |
779 |
$2K |
| 72110 |
|
24 |
24 |
$1K |
| 87070 |
|
106 |
79 |
$1K |
| 82947 |
|
99 |
87 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
1,456 |
1,318 |
$1K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
56 |
55 |
$1K |
| 71020 |
|
27 |
14 |
$1K |
| Z7610 |
|
124 |
54 |
$1K |
| 87075 |
|
74 |
59 |
$1K |
| Z9725 |
|
24 |
24 |
$1K |
| 59025 |
Fetal non-stress test |
44 |
24 |
$981.03 |
| J7050 |
Infusion, normal saline solution, 250 cc |
113 |
102 |
$939.88 |
| 87581 |
|
15 |
14 |
$861.72 |
| 87486 |
|
15 |
14 |
$861.72 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
25 |
16 |
$820.56 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
15 |
14 |
$816.59 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
15 |
14 |
$795.85 |
| 87205 |
|
100 |
80 |
$735.90 |
| J2704 |
Injection, propofol, 10 mg |
40 |
39 |
$591.17 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
56 |
54 |
$474.92 |
| 84702 |
|
42 |
38 |
$341.65 |
| 85652 |
|
100 |
97 |
$290.86 |
| 73140 |
|
13 |
12 |
$233.54 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
193 |
171 |
$230.40 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
178 |
158 |
$222.46 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
41 |
41 |
$207.83 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
151 |
139 |
$189.56 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
28 |
28 |
$188.91 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
29 |
26 |
$181.78 |
| 87420 |
|
14 |
14 |
$150.93 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
17 |
13 |
$117.86 |
| S0028 |
Injection, famotidine, 20 mg |
12 |
12 |
$90.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
14 |
14 |
$84.02 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
47 |
43 |
$61.17 |
| 86901 |
|
12 |
12 |
$55.14 |
| 86900 |
|
16 |
13 |
$46.10 |
| 80061 |
Lipid panel |
12 |
12 |
$19.25 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
13 |
13 |
$8.60 |